Literature DB >> 2848918

B cell activation and the establishment of Epstein-Barr virus latency.

E A Hurley1, D A Thorley-Lawson.   

Abstract

Linear EBV genomes undergo a transition to the circular form characteristic of latency by 16-20 h post-infection. This transition requires that the infected cells be activated to the G1 stage of the cell cycle. Cellular proliferation and expression of the activation marker CD23 were not required. Nevertheless, 36 h post-infection, only cells expressing CD23 contained covalently closed, circular episomes (CCC), at an average of one copy per cell. Since the presence of CD23 at this time is predictive that a cell will immortalize, we suggest that the presence of CCC is required for CD23 expression and subsequent immortalization. The one CCC present in each CD23+ cell did not undergo amplification until well after the cells had acquired all of the characteristic phenotypic markers of immortalization. Therefore, while amplification is not necessary for proliferation and immortalization, circularization of a single genome is crucial to the establishment and maintenance of latency by EBV.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848918      PMCID: PMC2189139          DOI: 10.1084/jem.168.6.2059

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

Review 1.  Evolution of tumours and the impact of molecular oncology.

Authors:  G Klein; E Klein
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

2.  Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons.

Authors:  S H Speck; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

Authors:  D Wang; D Liebowitz; E Kieff
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

4.  Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA.

Authors:  T Matsuo; M Heller; L Petti; E O'Shiro; E Kieff
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

5.  Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis.

Authors:  T Gardella; P Medveczky; T Sairenji; C Mulder
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

6.  Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.

Authors:  M Rabson; L Gradoville; L Heston; G Miller
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

7.  Herpesvirus sylvilagus infects both B and T lymphocytes in vivo.

Authors:  W J Kramp; P Medveczky; C Mulder; H C Hinze; J L Sullivan
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

8.  Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro.

Authors:  A Henderson; S Ripley; M Heller; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

9.  A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome.

Authors:  G Laux; M Perricaudet; P J Farrell
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

10.  Early events in Epstein-Barr virus infection provide a model for B cell activation.

Authors:  D A Thorley-Lawson; K P Mann
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

View more
  52 in total

1.  CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.

Authors:  S Nikiforow; K Bottomly; G Miller
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Sp1 binds to the precise locus of end processing within the terminal repeats of Epstein-Barr virus DNA.

Authors:  R Sun; T A Spain; S F Lin; G Miller
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.

Authors:  Daniel Salamon; Monika Adori; Dorina Ujvari; Liang Wu; Lorand L Kis; Harsha S Madapura; Noemi Nagy; George Klein; Eva Klein
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 4.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

5.  Early establishment of gamma-herpesvirus latency: implications for immune control.

Authors:  Emilio Flaño; Qingmei Jia; John Moore; David L Woodland; Ren Sun; Marcia A Blackman
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

6.  The infectious kiss: newly infected B cells deliver Epstein-Barr virus to epithelial cells.

Authors:  Georg W Bornkamm; Uta Behrends; Josef Mautner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

7.  Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI.

Authors:  P A Clarke; M Schwemmle; J Schickinger; K Hilse; M J Clemens
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

8.  Epstein-barr virus-induced changes in B-lymphocyte gene expression.

Authors:  Kara L Carter; Ellen Cahir-McFarland; Elliott Kieff
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48).

Authors:  R C Fisher; D A Thorley-Lawson
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

10.  When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.

Authors:  E A Hurley; S Agger; J A McNeil; J B Lawrence; A Calendar; G Lenoir; D A Thorley-Lawson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.